FOR FURTHER INFORMATION

shadow

If you have any questions or concerns about any of the vaccines mentioned visit www.medsafe.govt.nz or talk to your healthcare professional.

For further information regarding GSK products please contact GSK at the following link.  contact us here

Additional Consumer Medicine Information is available at:
http://www.medsafe.govt.nz/Consumers/cmi/v/Varilrix.pdf

Varilrix® (live attenuated varicella vaccine) is available as an injection.  Varilrix is a private-purchase prescription medicine for immunisation and prophylaxis against varicella (chickenpox) in adults and children older than 9 months. You will need to pay for this medicine.  Children aged 13 years and older need two doses with an interval between doses of at least 6 weeks. Two doses at least 6 weeks apart are also recommended for children aged between 9 months and 12 years, to provide optimal protection. Use strictly as directed.  Do not have a Varilrix injection if you are allergic to Varilrix or to the antibiotic neomycin, if you have a high fever, if you have a condition that causes lack of immunocompetence, or if you are pregnant.  Pregnancy should be avoided for 3 months after vaccination.  Tell your doctor before you have the vaccine if you have a lowered resistance to disease or have a severe chronic disease.  Common side effects: mild rash, a small number of chicken-pox-like blisters, or pain, redness and swelling at the injection site. Uncommon side effects include fever, headache, cough, vomiting, swollen lymph nodes, and joint pain.  If you have any side effects, see your doctor, pharmacist, or health professional.  Additional Consumer Medicine Information for Varilrix is available at www.medsafe.govt.nz.  Prices for Varilrix may vary across doctor's clinics.  Normal doctor's office visit fees apply.  Ask your doctor if Varilrix is right for you.

Varilrix is a registered trade mark of the GlaxoSmithKline group of companies. Marketed by GlaxoSmithKline NZ Limited, Auckland.

Adverse events involving GSK products should be reported to GSK Medical Information on 0800 808 500.

GSK NZ Limited, Auckland, New Zealand. Updated 01.06.14. TAPS NA 7116/14MY/VAR/0013/13
We cannot answer questions on vaccines through this website or via email.
If you are a patient and have specific questions or information regarding any GSK prescription medicines, please first consult your doctor or healthcare professional. If you have a question about a GSK vaccine or would like to report an adverse event, please call Medical Information on 0800 808 500 or 09 3672900. Contact details for countries other than New Zealand can be found at http://www.gsk.com/contactus.htm


Clicking this link will take you to an independent non GSK site that may contain content that does not necessarily reflect the views of GSK or the licenced indications for the use of GSK products.